Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants
Clinical trial NCT03978143 · COMPLETED
Trial details
- NCT number
- NCT03978143
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2019-10-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.